Assessment of MRI to estimate metastatic dissemination risk and prometastatic effects of chemotherapy.
Karagiannis GS, Bianchi A, Sanchez LR, Ambadipudi K, Cui MH, Anampa JM, Asiry S, Wang Y, Harney AS, Pastoriza JM, Lin Y, Chen X, Jones JG, Entenberg D, Haddad D, Hodges LJ, Duong TQ, Sparano JA, Oktay MH, Branch CA, Condeelis JS.
Karagiannis GS, et al. Among authors: sanchez lr.
NPJ Breast Cancer. 2022 Sep 2;8(1):101. doi: 10.1038/s41523-022-00463-5.
NPJ Breast Cancer. 2022.
PMID: 36056005
Free PMC article.